Compare OPXS & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OPXS | NSPR |
|---|---|---|
| Founded | 1987 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electronic Components | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 89.0M | 81.8M |
| IPO Year | N/A | N/A |
| Metric | OPXS | NSPR |
|---|---|---|
| Price | $14.13 | $1.94 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $4.50 |
| AVG Volume (30 Days) | 34.5K | ★ 101.5K |
| Earning Date | 12-17-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 23.32 | N/A |
| EPS | ★ 0.75 | N/A |
| Revenue | ★ $39,481,000.00 | $7,779,000.00 |
| Revenue This Year | N/A | $22.76 |
| Revenue Next Year | N/A | $75.45 |
| P/E Ratio | $20.35 | ★ N/A |
| Revenue Growth | ★ 21.00 | 14.04 |
| 52 Week Low | $5.36 | $1.59 |
| 52 Week High | $17.76 | $3.80 |
| Indicator | OPXS | NSPR |
|---|---|---|
| Relative Strength Index (RSI) | 47.55 | 47.60 |
| Support Level | $13.09 | $1.74 |
| Resistance Level | $15.44 | $2.00 |
| Average True Range (ATR) | 0.84 | 0.12 |
| MACD | 0.10 | 0.01 |
| Stochastic Oscillator | 47.31 | 48.72 |
Optex Systems Holdings Inc manufactures optical sighting systems and assemblies for the U.S. Department of Defense, foreign military applications, and commercial markets. Its products are installed on a variety of United States military land vehicles, such as the Abrams and Bradley fighting vehicles, and light armored and security vehicles, and have been selected for installation on the Stryker family of vehicles. The company's operating segment includes Optex Systems Richardson and Applied Optics Center Dallas and others. It generates maximum revenue from the Optex Systems Richardson segment. Some of its products include M17 Day/Thermal Periscope; DDAN / M36 Sights; Laser Protected Periscopes; Muzzle Reference Sensor and others.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.